Status:
COMPLETED
Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Arrhythmia
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To determine the benefits and risks of oral anticoagulant therapy in reducing embolic stroke and systemic emboli in patients with atrial fibrillation without rheumatic heart disease.
Detailed Description
BACKGROUND: The efficacy of oral anticoagulation therapy in reducing the risk of embolic stroke in patients with atrial fibrillation and rheumatic heart disease was well known. The value of anticoagu...
Eligibility Criteria
Men and women, 18 years of age or older, with non-rheumatic atrial fibrillation.
Key Trial Info
Start Date :
July 1 1985
Trial Type :
INTERVENTIONAL
End Date :
June 1 1991
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000517
Start Date
July 1 1985
End Date
June 1 1991
Last Update
April 10 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.